• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W.L. GORE & ASSOCIATES AORTIC EXCLUDER ILIAC BRANCH ENDOPROSTHESIS (IBE); SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W.L. GORE & ASSOCIATES AORTIC EXCLUDER ILIAC BRANCH ENDOPROSTHESIS (IBE); SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT Back to Search Results
Catalog Number HGB161207
Device Problem Material Invagination (1336)
Patient Problem Aneurysm (1708)
Event Date 10/23/2018
Event Type  malfunction  
Manufacturer Narrative
(b)(4).The device was discarded at the facility and not available for analysis.The gore® excluder® iliac branch endoprosthesis instructions for use (ifu) states: do not continue advancing and withdrawing any portion of the delivery system if resistance is felt during advancement of the guidewire, sheath, or catheter.Stop and assess the cause of resistance.Vessel or catheter damage may occur.According to the gore® excluder® iliac branch endoprosthesis instructions for use (ifu), additional considerations for patient selection include but are not limited to patient¿s anatomical suitability for endovascular repair.
 
Event Description
On (b)(6) 2018, a gore® excluder® iliac branch endoprostheses (ibe) was intended to be used to treat a patient¿s bilateral common iliac artery (cia) aneurysms.The right iliac branch endoprosthesis was successfully implanted.During the implant process an internal iliac component ((b)(4)) would not track into the gate of the ibe, appearing to catch on the flow divider.The sheath was repositioned, however ultimately the decision was made to remove the device.While attempting to remove the device, visible compression of the stent was identified.It was reported that the ostium was noted to be narrow.The procedure was completed using additional devices.The patient tolerated the procedure.
 
Manufacturer Narrative
This report is being sent as a retraction to the initial report.Additional information received from the product manager demonstrated the device did not deploy, still remained on the catheter, and the device was not compressed as originally reported.Based on this additional clarification, the event no longer meets the criteria of a reportable malfunction, therefore gore is retracting this report.
 
Event Description
This report is being sent as a retraction to the initial report.Additional information received from the product manager demonstrated the device did not deploy, still remained on the catheter, and the device was not compressed as originally reported.Based on this additional clarification, the event no longer meets the criteria of a reportable malfunction, therefore gore is retracting this report.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AORTIC EXCLUDER ILIAC BRANCH ENDOPROSTHESIS (IBE)
Type of Device
SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
Manufacturer (Section D)
W.L. GORE & ASSOCIATES
flagstaff AZ
MDR Report Key8081057
MDR Text Key128410731
Report Number3013164176-2018-00110
Device Sequence Number1
Product Code MIH
Combination Product (y/n)N
PMA/PMN Number
P020004
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Type of Report Initial,Followup
Report Date 12/04/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date12/06/2020
Device Catalogue NumberHGB161207
Device Lot Number17532117
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Initial Date Manufacturer Received Not provided
Initial Date FDA Received11/16/2018
Supplement Dates Manufacturer ReceivedNot provided
Supplement Dates FDA Received12/10/2018
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Age79 YR
-
-